American Geriatrics

Medicare Part D Plans' Coverage and Cost-Sharing for Acute Rescue and Preventive Inhalers for Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States, 1 affecting 15.7 million adults 1 and causing nearly 700 000 hospitalizations and 1.7 million emergency department visits in 2012. 2 Much of the burden of COPD falls heavily on Medicare, with 1 in 9 Medicare beneficiaries diagnosed as having COPD 3 and Medicare paying 51% of all US direct health care costs for COPD. 4 Inhaled medications are key to relieving symptoms and improving health outcomes. However, up to 31% of Medicare beneficiaries using COPD inhalers have reported nonadherence owing to cost.
5
COPD inhaler costs increased dramatically in 2008, when a ban on chlorofluorocarbon propellants phased out generic inhalers, leaving only brand-name options. 6 We examined coverage and cost-sharing for COPD inhalers in Medicare Part D plans, which covered 39 million beneficiaries in 2015. (Table) . The projected annual out-of-pocket cost under a standard 2015 Part D benefit ranged from $494 to $1197 for the most widely covered inhaler in each class (Figure) . For 5 of 7 classes, using a single inhaler each month would have produced annual out-of-pocket costs of at least $900 and caused beneficiaries to reach the coverage gap even without other medications. Patients with moderate to severe COPD requiring 2 or 3 inhalers per month (acute rescue and/or multiple preventive classes) would have had projected annual out-of-pocket expenses of $1622 to $2811, reaching the coverage gap by August or earlier.
Most MA-PD and PDP plans (≥92%) covered at least 1 inhaler per class, although MA-PD plans covered specific inhalers more frequently (Table) ; for 20 of 21 inhalers, the percentage of MA-PD plans providing coverage was 2% to 39% greater than PDP plans. However, MA-PD plans required higher out-of-pocket costs than PDP plans for 14 of 21 inhalers, with cost-sharing ranging from $2 to $46 higher per inhaler.
Discussion | In our nationwide analysis of Medicare Part D plans, COPD inhalers were nearly universally covered but required high cost-sharing by beneficiaries. For many acute rescue and preventive inhalers, using a single inhaler each month had projected annual out-of-pocket costs of at least $900 under a standard 2015 Part D plan even without other medications.
Our study limitations include projecting annual costsharing for each inhaler based on using 1 inhaler per month and no other prescriptions. We did not examine actual out-ofpocket costs, which reflect a beneficiary's coverage phase when filling an inhaler prescription, which in turn is influenced by their non-COPD medication costs.
Our findings call into question whether Part D continues to adequately support beneficiaries in the face of rapidly rising drug prices. Part D plans and Medicare policy should reassess whether this high cost-sharing adversely affects inhaler adherence and health for beneficiaries with COPD. 
Changes in Primary Care Access Between 2012 and 2016 for New Patients With Medicaid and Private Coverage
Millions of uninsured adults in the United States have gained health insurance under the Affordable Care Act since major coverage provisions of the act were implemented in 2014, including federal funding for an extension of Medicaid eligibility to nonelderly and low-income adults in some states. 1 Anticipating heightened demand, policymakers launched concurrent initiatives to strengthen primary care delivery, such as raising Medicaid reimbursement to Medicare levels for certain primary care providers in 2013 and 2014, 2 increasing funds for federally qualified health centers 3 and expanding the penetration of Medicaid managed care. 4 Methods | In this audit study, simulated patients requested new patient appointments from primary care practices in Arkansas, Georgia, Illinois, Iowa, Massachusetts, Montana, New Jersey, Oregon, Pennsylvania, and Texas. To assess the Affordable Care Act's effect on primary care access, a baseline study 5 from 2012-2013 was repeated in 2016 with an updated sample of practices.
Eligible practices had at least 1 primary care physician who served nonelderly adults and participated in a provider network within a caller's insurance type. A nondeceptive and pre-audit survey verified eligibility and identified a specific in-network plan. This study, performed from November 13, 2012, to April 3, 2013, and from February 8, 2016, to June 16, 2016, was approved by the institutional review board of the University of Pennsylvania. The requirement for informed consent was waived, and we have protected the confidentiality of individual practices. Callers varied by age, sex, and race/ethnicity and were randomized to an insurance type (Medicaid or private coverage) and clinical scenario (hypertension or check-up). They requested the earliest appointment available with a randomly selected primary care physician within each practice but, if necessary, accepted appointments with another primary care physician or midlevel provider. Callers requested an appointment using an in-network plan, recorded whether an appointment was granted and what date it was scheduled, and then cancelled the appointment. More detail on our methodology is available elsewhere. 2, 5 We analyzed changes between 2012-2013 and 2016 in appointment availability and the probability of short wait times (≤1 week) and long wait times (>30 days). We tested for significant differences in means using 2-tailed tests, weights, and county-clustered SEs.
Results | Across the 10 states, for Medicaid callers, appointment availability increased 5.4 percentage points (95% CI, 2.1-8.6) ( Table 1 ) and short wait times decreased 6.7 percentage points (95% CI, −10.1 to −3.3) ( Table 2 ) between 2012-2013 and 2016. For privately insured callers, there was no significant change in appointment availability, although short wait times decreased 4.1 percentage points (95% CI, −6.3 to −1.9) and long wait times increased 3.3 percentage points (95% CI, 1.9-4.8). The gap in appointment availability between insurance types narrowed, but Medicaid rates still lagged behind private coverage in 2016.
Medicaid callers experienced increasing appointment availability in Illinois (20.0 percentage points; 95% CI, 11.4-28.5), Iowa (8.1 percentage points; 95% CI, 1.2-15.0), and Pennsylvania (7.2 percentage points; 95% CI, 0.0-14.5). Privately insured callers experienced increasing appointment availability in Pennsylvania (6.5 percentage points; 95% CI, 1.9-11.2) but faced decreases in Oregon (−8.9 percentage points; 95% CI, −16.4 to −1.5) and Arkansas (−5.1 percentage points; 95% CI, −9.4 to −0.8). There was no significant change in appointment availability for either insurance type in Georgia, Massachusetts, Montana, New Jersey, or Texas.
Discussion | Between 2012-2013 and 2016, appointment availability increased for Medicaid callers and remained stable for privately insured callers. Short wait times (≤1 week) decreased for callers with both insurance types, and long wait times (>30 days) increased for callers with private coverage.
The appointment availability results should ease concerns that the Affordable Care Act would exacerbate the primary care shortage. The increase in appointment availability is particularly surprising given the expiration of the Medicaid rate increase in most states. 2 Primary care practices may be adapting to an influx of new patients with shorter visits and more rigorous management of no-shows. The absorption of patients can explain the longer wait times, which was similarly observed in Massachusetts after it expanded Medicaid in 2006. 6 Beyond Affordable Care Act initiatives, changes that may have further expanded capacity include team-based practices, retail clinics, and data sharing.
